Literature DB >> 10690853

Decrease of free thyroxine levels after controlled ovarian hyperstimulation.

A F Muller1, A Verhoeff, M J Mantel, F H De Jong, A Berghout.   

Abstract

Controlled ovarian hyperstimulation could lead to opposing effects on thyroid function. Therefore, in a prospective study of 65 women undergoing controlled ovarian hyperstimulation, thyroid hormones, T4-binding globulin, TPO antibodies, gonadotropins, estradiol, and PRL were measured before and after controlled ovarian hyperstimulation. After ovarian stimulation (mean +/- SE of mean): free T4 decreased, 14.4 +/- 0.2 vs. 12.9 +/- 0.2 pmol/L (P < 0.0001); thyroid-stimulating hormone increased, 2.3 +/- 0.3 vs. 3.0 +/- 0.4 mU/L (P < 0.0001); T4-binding globulin increased, 25.2 +/- 0.7 vs. 33.9 +/- 0.9 mg/L (P < 0.0001); total T4 increased, 98.1 +/- 2.3 vs. 114.6 +/- 2.5 nmol/L (P < 0.0001); total T3 increased, 2.0 +/- 0.04 vs. 2.3 +/- 0.07 nmol/L (P < 0.0001); TPO antibodies decreased, 370 +/- 233 U/mL vs. 355 +/- 224 U/mL (P < 0.0001); LH decreased, 8.1 +/- 1.1 vs. 0.4 +/-0.1 U/L (P < 0.0001); FSH did not change, 6.5 +/- 0.6 vs. 7.9 +/- 0.9 U/L (P = 0.08); human CG increased, <2 +/- 0.0 vs. 195 +/- 16 U/L (P < 0.0001); estradiol increased, 359.3 +/- 25.9 pmol/L vs. 3491.8 +/-298.3 pmol/L (P < 0.0001); and PRL increased, 0.23 +/- 0.02 vs. 0.95 +/- 0.06 U/L (P < 0.0001). Because low maternal free T4 and elevated maternal thyroid-stimulating hormone levels during early gestation have been reported to be associated with impaired psychomotor development in the offspring, our findings indicate the need for additional studies in the children of women who where exposed to high levels of estrogens around the time of conception.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10690853     DOI: 10.1210/jcem.85.2.6374

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  16 in total

1.  Thyroid function during controlled ovarian hyperstimulation as part of in vitro fertilization.

Authors:  Clarisa R Gracia; Christopher B Morse; Grace Chan; Samantha Schilling; Maureen Prewitt; Mary D Sammel; Susan J Mandel
Journal:  Fertil Steril       Date:  2012-01-18       Impact factor: 7.329

2.  Effect of autoimmune thyroid disease in older euthyroid infertile woman during the first 35 days of an IVF cycle.

Authors:  Andrea Reh; Sonal Chaudhry; Felicia Mendelsohn; Shelly Im; Linda Rolnitzky; Alana Amarosa; Mortimer Levitz; Suman Srinivasa; Lewis Krey; Alan S Berkeley; James A Grifo; Ann Danoff
Journal:  Fertil Steril       Date:  2010-11-03       Impact factor: 7.329

3.  Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.

Authors:  Jacqueline Jonklaas; Antonio C Bianco; Andrew J Bauer; Kenneth D Burman; Anne R Cappola; Francesco S Celi; David S Cooper; Brian W Kim; Robin P Peeters; M Sara Rosenthal; Anna M Sawka
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

4.  2021 European Thyroid Association Guideline on Thyroid Disorders prior to and during Assisted Reproduction.

Authors:  Kris Poppe; Peter Bisschop; Laura Fugazzola; Gesthimani Minziori; David Unuane; Andrea Weghofer
Journal:  Eur Thyroid J       Date:  2021-01-21

5.  Thyroid stimulating hormone levels rise after assisted reproductive technology.

Authors:  Shauna Reinblatt; Belen Herrero; José A Correa; Einat Shalom-Paz; Baris Ata; Amir Wiser; David Morris; Hananel Holzer
Journal:  J Assist Reprod Genet       Date:  2013-08-18       Impact factor: 3.412

6.  In vitro fertilization pregnancy rates in levothyroxine-treated women with hypothyroidism compared to women without thyroid dysfunction disorders.

Authors:  Bert Scoccia; Habibe Demir; Yuna Kang; Michelle A Fierro; Nicola J Winston
Journal:  Thyroid       Date:  2012-04-27       Impact factor: 6.568

7.  Thyroglobulin autoantibodies: is there any added value in the detection of thyroid autoimmunity in women consulting for fertility treatment?

Authors:  David Unuane; Brigitte Velkeniers; Ellen Anckaert; Johan Schiettecatte; Herman Tournaye; Patrick Haentjens; Kris Poppe
Journal:  Thyroid       Date:  2013-08       Impact factor: 6.568

8.  Changes in thyroid function during controlled ovarian hyperstimulation (COH) and its impact on assisted reproduction technology (ART) outcomes: a systematic review and meta-analysis.

Authors:  Danpei Li; Sitao Hu; Xiaoyu Meng; Xuefeng Yu
Journal:  J Assist Reprod Genet       Date:  2021-04-30       Impact factor: 3.357

9.  Birth control pills and risk of hypothyroidism: a cross-sectional study of the National Health and Nutrition Examination Survey, 2007-2012.

Authors:  Yuxuan Qiu; Yuanyuan Hu; Zhichao Xing; Qingyu Fu; Jingqiang Zhu; Anping Su
Journal:  BMJ Open       Date:  2021-06-23       Impact factor: 2.692

10.  Impact of Thyroid Autoimmunity on In Vitro Fertilization/Intracytoplasmic Sperm Injection Outcomes and Fetal Weight.

Authors:  Ning Huang; Lixue Chen; Ying Lian; Haining Wang; Rong Li; Jie Qiao; Hongbin Chi
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-08       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.